Cargando…
Mutation and immune profiling of metaplastic breast cancer: Correlation with survival
The goal of this study is to characterize the genomic and immune profiles of metaplastic breast cancer (MpBC) and identify the association with survival through an analysis of archived tumor tissue. A next-generation sequencing-based mutational assay (Onco-48) was performed for 21 MpBC patients. Cli...
Autores principales: | Afkhami, Michelle, Schmolze, Daniel, Yost, Susan E., Frankel, Paul H., Dagis, Andrew, Amanam, Idoroenyi U., Telatar, Milhan, Nguyen, Kim, Yu, Kim Wai, Luu, Thehang, Pillai, Raju, Aoun, Patricia A., Mortimer, Joanne, Yuan, Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834262/ https://www.ncbi.nlm.nih.gov/pubmed/31693690 http://dx.doi.org/10.1371/journal.pone.0224726 |
Ejemplares similares
Cargando…
Totally Ossified Metaplastic Spinal Meningioma
por: Ju, Chang Il, et al.
Publicado: (2013)
por: Ju, Chang Il, et al.
Publicado: (2013)
Ejemplares similares
-
Phase I clinical trial of the combination of eribulin and everolimus in patients with metastatic triple-negative breast cancer
por: Lee, Jin Sun, et al.
Publicado: (2019) -
Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis
por: He, Ting-Fang, et al.
Publicado: (2020) -
Targeted Therapies for Pancreatic Cancer
por: Amanam, Idoroenyi, et al.
Publicado: (2018) -
Pathway activity profiling of growth factor receptor network and stemness pathways differentiates metaplastic breast cancer histological subtypes
por: McQuerry, Jasmine A., et al.
Publicado: (2019) -
Phase 2 prospective open label study of neoadjuvant nab‐paclitaxel, trastuzumab, and pertuzumab in patients with HER2‐positive primary breast cancer
por: Lavasani, Sayeh M., et al.
Publicado: (2022)